SANXING Medical will repurchase and cancel 41,800 restricted stocks

Ningbo SANXING Medical Electric Co., Ltd. announced that due to the departure of 5 incentive targets in the fourth and fifth phases of the restricted stock incentive plan, which do not meet the incentive conditions, the company will repurchase and cancel 41,800 shares of restricted stock that have been granted but not yet released from restrictions. The cancellation is expected to be completed by September 12, 2025. After the completion of this repurchase and cancellation, the company's total share capital will change from 1,405,251,200 shares to 1,405,209,400 shares. The company stated that the decision-making process for this repurchase and cancellation, as well as information disclosure, is compliant, and there are no circumstances that harm the rights and interests of relevant parties. The relevant information has been verified and ensured to be true, accurate, and complete